203 related articles for article (PubMed ID: 18832825)
1. Atenolol is inferior to metoprolol in improving left ventricular function and preventing ventricular remodeling in dogs with heart failure.
Zacà V; Rastogi S; Mishra S; Wang M; Sharov VG; Gupta RC; Goldstein S; Sabbah HN
Cardiology; 2009; 112(4):294-302. PubMed ID: 18832825
[TBL] [Abstract][Full Text] [Related]
2. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure.
Imai M; Rastogi S; Gupta RC; Mishra S; Sharov VG; Stanley WC; Mika Y; Rousso B; Burkhoff D; Ben-Haim S; Sabbah HN
J Am Coll Cardiol; 2007 May; 49(21):2120-8. PubMed ID: 17531662
[TBL] [Abstract][Full Text] [Related]
3. Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.
Rastogi S; Sharov VG; Mishra S; Gupta RC; Blackburn B; Belardinelli L; Stanley WC; Sabbah HN
Am J Physiol Heart Circ Physiol; 2008 Nov; 295(5):H2149-55. PubMed ID: 18820026
[TBL] [Abstract][Full Text] [Related]
4. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
6. Chronic monotherapy with rosuvastatin prevents progressive left ventricular dysfunction and remodeling in dogs with heart failure.
Zacà V; Rastogi S; Imai M; Wang M; Sharov VG; Jiang A; Goldstein S; Sabbah HN
J Am Coll Cardiol; 2007 Aug; 50(6):551-7. PubMed ID: 17678740
[TBL] [Abstract][Full Text] [Related]
7. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.
Groenning BA; Nilsson JC; Sondergaard L; Fritz-Hansen T; Larsson HB; Hildebrandt PR
J Am Coll Cardiol; 2000 Dec; 36(7):2072-80. PubMed ID: 11127443
[TBL] [Abstract][Full Text] [Related]
8. Autoantibody against beta1-adrenergic receptor and left ventricular remodeling changes in response to metoprolol treatment.
Miao GB; Liu JC; Liu MB; Wu JL; Zhang G; Chang J; Zhang L
Eur J Clin Invest; 2006 Sep; 36(9):614-20. PubMed ID: 16919043
[TBL] [Abstract][Full Text] [Related]
9. Effect of beta-blockade on left atrial contribution to ventricular filling in dogs with moderate heart failure.
Shimoyama H; Sabbah HN; Rosman H; Alam M; Goldstein S
Am Heart J; 1996 Apr; 131(4):772-7. PubMed ID: 8721654
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Morita H; Suzuki G; Mishima T; Chaudhry PA; Anagnostopoulos PV; Tanhehco EJ; Sharov VG; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2002 Sep; 16(5):443-9. PubMed ID: 12652114
[TBL] [Abstract][Full Text] [Related]
11. Effects of long-term therapy with bosentan on the progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Mishima T; Tanimura M; Suzuki G; Todor A; Sharov VG; Goldstein S; Sabbah HN
J Am Coll Cardiol; 2000 Jan; 35(1):222-9. PubMed ID: 10636284
[TBL] [Abstract][Full Text] [Related]
12. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
Suzuki G; Khanal S; Rastogi S; Morita H; Mishima T; Anagnostopoulos PV; Nass O; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2007 Feb; 21(1):29-36. PubMed ID: 17294127
[TBL] [Abstract][Full Text] [Related]
13. Effect of beta-blockers on beta3-adrenoceptor expression in chronic heart failure.
Zhao Q; Wu TG; Jiang ZF; Chen GW; Lin Y; Wang LX
Cardiovasc Drugs Ther; 2007 Apr; 21(2):85-90. PubMed ID: 17440824
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction.
Sabbah HN; Shimoyama H; Kono T; Gupta RC; Sharov VG; Scicli G; Levine TB; Goldstein S
Circulation; 1994 Jun; 89(6):2852-9. PubMed ID: 8205701
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of beta-blockers on left ventricular dyssynchrony and reverse remodeling in idiopathic dilated cardiomyopathy: A randomized trial of carvedilol and metoprolol.
Kaya MG; Sarli B; Akpek M; Kaya EG; Yarlioglues M; Topsakal R; Lam YY
Cardiol J; 2014; 21(4):434-41. PubMed ID: 24142686
[TBL] [Abstract][Full Text] [Related]
16. Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure.
Suzuki G; Morita H; Mishima T; Sharov VG; Todor A; Tanhehco EJ; Rudolph AE; McMahon EG; Goldstein S; Sabbah HN
Circulation; 2002 Dec; 106(23):2967-72. PubMed ID: 12460880
[TBL] [Abstract][Full Text] [Related]
17. Bradycardic therapy improves left ventricular function and remodeling in dogs with coronary embolization-induced chronic heart failure.
Cheng Y; George I; Yi GH; Reiken S; Gu A; Tao YK; Muraskin J; Qin S; He KL; Hay I; Yu K; Oz MC; Burkhoff D; Holmes J; Wang J
J Pharmacol Exp Ther; 2007 May; 321(2):469-76. PubMed ID: 17277196
[TBL] [Abstract][Full Text] [Related]
18. Chronic therapy with metoprolol attenuates cardiomyocyte apoptosis in dogs with heart failure.
Sabbah HN; Sharov VG; Gupta RC; Todor A; Singh V; Goldstein S
J Am Coll Cardiol; 2000 Nov; 36(5):1698-705. PubMed ID: 11079679
[TBL] [Abstract][Full Text] [Related]
19. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
Omerovic E; Bollano E; Soussi B; Waagstein F
Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
[TBL] [Abstract][Full Text] [Related]
20. [The effects of combined beta(1) adrenergic receptor antagonist and beta(2) adrenergic receptor agonist therapy on cardiac function and myocardial apoptosis in heart failure rats].
Li WM; Gan RT; Wang X; Wu S; Shen JX; Xiu CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jul; 35(7):615-9. PubMed ID: 17961425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
